# TMC207-TiDP13-C110: Interaction Study With Lopinavir/Ritonavir in Healthy Volunteer

> **NCT00828529** · PHASE1 · COMPLETED · sponsor: **Tibotec BVBA** · enrollment: 16 (actual)

## Conditions studied

- Tuberculosis
- HIV

## Interventions

- **DRUG:** TMC207

## Key facts

- **NCT ID:** NCT00828529
- **Lead sponsor:** Tibotec BVBA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2012-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00828529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00828529, "TMC207-TiDP13-C110: Interaction Study With Lopinavir/Ritonavir in Healthy Volunteer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00828529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*